Trial no.:
|
PACTR202008687031377 |
Date of Approval:
|
11/08/2020 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Suprazygomatic maxillary nerve block in septorhinoplasty. |
Official scientific title |
Efficacy of ultrasound-guided suprazygomatic maxillary nerve block on emergence agitation and postoperative analgesia after septorhinoplasty. A prospective randomized trial |
Brief summary describing the background
and objectives of the trial
|
Application of a multimodal approach for analgesia with systemic agents and regional nerve block techniques has been advocated for managing pain in septorhinoplasty when feasible. The preemptive analgesia produced by peripheral nerve blocks employed with general anesthesia has the advantage of providing a stable hemodynamic profile, good quality of recovery besides a reduction in both intra and postoperative analgesic requirements. In this study we will test the hypothesis that bilateral application of ultrasound-guided suprazygomatic maxillary nerve block could decrease the incidence of emergence agitation as a primary outcome, along with reduction in postoperative pain scores and total analgesic requirements as secondary outcomes in adult patients undergoing septorhinoplasty. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Other |
Anticipated trial start date |
20/07/2020 |
Actual trial start date |
|
Anticipated date of last follow up |
15/12/2020 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
60 |
Actual target sample size (number of participants) |
|
Recruitment status |
Completed |
Publication URL |
|
|